Sale!

Thalassemia Monitoring Panel Test Cost

Original price was: 910 د.إ.Current price is: 820 د.إ.

-10%

The Thalassemia Monitoring Panel Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to evaluate and monitor individuals diagnosed with thalassemia, a genetic blood disorder characterized by reduced hemoglobin production. This condition can lead to anemia, fatigue, and, in severe cases, organ damage. The test plays a crucial role in managing the disease effectively, helping healthcare providers tailor treatment plans to the patient’s specific needs.

At a cost of 820 AED, the Thalassemia Monitoring Panel Test encompasses a comprehensive analysis of various blood parameters and genetic markers associated with thalassemia. This includes evaluating the types and levels of hemoglobin present, identifying mutations or deletions in the genes responsible for hemoglobin production, and monitoring the overall health of red blood cells. By providing detailed insights into the patient’s condition, the test aids in assessing the severity of the disease, tracking its progression, and adjusting therapeutic interventions accordingly.

DNA Labs UAE, known for its advanced diagnostic facilities and expertise in genetic testing, ensures high accuracy and reliability of the Thalassemia Monitoring Panel Test. Patients and healthcare providers can expect results that offer valuable guidance in the ongoing management of thalassemia, contributing to improved patient outcomes and quality of life.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Thalassemia Monitoring Panel Test

At DNA Labs UAE, we offer the Thalassemia Monitoring Panel test, a diagnostic tool used to assess and monitor individuals with thalassemia. Thalassemia is a group of genetic blood disorders that affect the production of hemoglobin. This panel includes several tests that provide important information about the type and severity of thalassemia, as well as the effectiveness of treatment.

Test Components

  • Z021: Complete Blood Count (CBC)
  • H060: Ferritin
  • B032: SGOT; Aspartate Aminotransferase (AST)
  • B033: SGPT; Alanine Aminotransferase (ALT)
  • B023: Creatinine, Serum
  • B022: BUN; Blood Ureanitrogen
  • B042: Calcium, Serum
  • B043: Phosphorus, Serum
  • B001: Glucose Fasting (F)
  • R052: TSH (Thyroid Stimulating Hormone)
  • S057: Hepatitis B Surface Antibody; Anti HBs
  • S010: HIV 1 & 2 Antibodies, Screening Test
  • S062: Hepatitis C Antibody (Anti-HCV)

Test Cost

The cost of the Thalassemia Monitoring Panel test is AED 820.0.

Symptoms and Diagnosis

Thalassemia can cause symptoms such as fatigue, weakness, pale skin, and shortness of breath. Diagnosis of thalassemia is typically made through a combination of physical examination, medical history, and laboratory tests, including the Thalassemia Monitoring Panel.

Sample Condition

The Thalassemia Monitoring Panel test requires a 3 mL (2 mL minimum) serum sample from 1 SST and 2 mL (1 mL minimum) plasma samples from 1 Grey Top (Sodium Fluoride) tube. Additionally, a 2 mL (1 mL minimum) plasma sample from 1 Lavender Top (EDTA) tube is required. The samples should be shipped refrigerated or frozen. It is important to note that hemolysed specimens are not acceptable. A duly filled Consent form for HIV testing & Pre-test counselling (Form 10 & 10A) is mandatory.

Report Delivery

The report for the Thalassemia Monitoring Panel test is delivered daily.

Method

The Thalassemia Monitoring Panel test utilizes electrical impedance, VCS spectrophotometry, and CLIA (Chemiluminescent Immunoassay) methods.

Test Type

The Thalassemia Monitoring Panel test falls under the category of Blood Disorders.

Doctor

This test is performed by a Hematologist.

Test Department

The Thalassemia Monitoring Panel test is conducted in our dedicated Test Department.

Pre Test Information

Minimum 8 hours fasting is mandatory before undergoing the Thalassemia Monitoring Panel test. Additionally, a duly filled Consent form for HIV testing & Pre-test counselling (Form 10 & 10A) is mandatory.

Test Details

The Thalassemia Monitoring Panel test includes several important tests:

  1. Complete Blood Count (CBC): This test measures the levels of red blood cells, white blood cells, and platelets in the blood. It can help identify anemia and determine the severity of thalassemia.
  2. Hemoglobin Electrophoresis: This test separates different types of hemoglobin based on their electrical charge. It can identify abnormal hemoglobin variants, such as hemoglobin S (found in sickle cell anemia) or hemoglobin E (found in certain types of thalassemia).
  3. Iron Studies: These tests measure the levels of iron in the blood, as well as other markers of iron metabolism. They can help determine if iron overload is present, which can occur in individuals who receive frequent blood transfusions to treat thalassemia.
  4. Serum Ferritin: This test measures the levels of ferritin, a protein that stores iron in the body. Elevated ferritin levels can indicate iron overload.
  5. Genetic Testing: This test involves analyzing the individual’s DNA to identify specific genetic mutations associated with thalassemia. It can help confirm the diagnosis and determine the specific type and severity of thalassemia.

The results of the Thalassemia Monitoring Panel test are crucial in guiding treatment decisions and monitoring the effectiveness of interventions such as blood transfusions, iron chelation therapy, or bone marrow transplantation. Regular monitoring is essential to ensure optimal management of thalassemia and prevent complications associated with the disorder.

Test Name THALASSEMIA MONITORING PANEL Test
Components *Z021* COMPLETE BLOOD COUNT;CBC *H060* FERRITIN *B032* SGOT; ASPARTATE AMINOTRANSFERASE (AST) *B033* SGPT; ALANINE AMINOTRANSFERASE (ALT) *B023* CREATININE,SERUM *B022* BUN; BLOOD UREANITROGEN *B042* CALCIUM,SERUM *B043* PHOSPHORUS,SERUM *B001* GLUCOSEFASTING (F) *R052* TSH (THYROID STIMULATING HORMONE) *S057* HEPATITIS B SURFACE ANTIBODY; ANTI HBs *S010* HIV 1 & 2 ANTIBODIES, SCREENING TEST *S062* HEPATITIS C ANTIBODY (Anti-HCV)
Price 820.0 AED
Sample Condition 3 mL (2 mL min.) serum from 1 SST AND 2 mL (1 mL min.) plasma from 1 Grey Top (Sodium Fluoride) tube. Ship refrigerated or frozen AND 2 mL (1 mL min.) plasma from 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Minimum 8 hours fasting is mandatory. Hemolysed specimensarenotacceptable. Duly filled Consent form for HIV testing & Pre-test counselling (Form 10 & 10A) is mandatory..
Report Delivery Daily
Method Electrical Impedance, VCS Spectrophotometry ,CLIA
Test type Blood Disorders
Doctor Hematologist
Test Department:
Pre Test Information Minimum 8 hours fasting is mandatory. Duly filled Consent form for HIV testing & Pre-test counselling (Form 10 & 10A) is mandatory.
Test Details

The Thalassemia Monitoring Panel test is a diagnostic tool used to assess and monitor individuals with thalassemia, a group of genetic blood disorders that affect the production of hemoglobin. This panel includes several tests that provide important information about the type and severity of thalassemia, as well as the effectiveness of treatment.

The Thalassemia Monitoring Panel typically includes the following tests:

1. Complete Blood Count (CBC): This test measures the levels of red blood cells, white blood cells, and platelets in the blood. It can help identify anemia and determine the severity of thalassemia.

2. Hemoglobin Electrophoresis: This test separates different types of hemoglobin based on their electrical charge. It can identify abnormal hemoglobin variants, such as hemoglobin S (found in sickle cell anemia) or hemoglobin E (found in certain types of thalassemia).

3. Iron Studies: These tests measure the levels of iron in the blood, as well as other markers of iron metabolism. They can help determine if iron overload is present, which can occur in individuals who receive frequent blood transfusions to treat thalassemia.

4. Serum Ferritin: This test measures the levels of ferritin, a protein that stores iron in the body. Elevated ferritin levels can indicate iron overload.

5. Genetic Testing: This test involves analyzing the individual’s DNA to identify specific genetic mutations associated with thalassemia. It can help confirm the diagnosis and determine the specific type and severity of thalassemia.

The results of the Thalassemia Monitoring Panel test can guide treatment decisions and help healthcare providers monitor the effectiveness of interventions such as blood transfusions, iron chelation therapy, or bone marrow transplantation. Regular monitoring is essential to ensure optimal management of thalassemia and prevent complications associated with the disorder.